AI Summary Advagraf (tacrolimus) is an extended-release capsule taken once daily to prevent organ rejection after liver transplantation.
Medically reviewed.
Advagraf (tacrolimus) is an extended-release form of tacrolimus, an immunosuppressant used to prevent organ rejection after liver transplantation. It provides once-daily dosing while maintaining effective immunosuppression. Advagraf works by calming the immune cells that can attack the transplanted liver, helping protect long-term graft function. Treatment decisions should always be individualized and guided by your transplant healthcare team.
This page covers Advagraf's role after liver transplant — how it works, who may be prescribed it, how it is used, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Advagraf fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT ADVAGRAF TREATMENT
Advagraf is a prescription medicine that contains tacrolimus, a type of medication called an immunosuppressant. It is an extended-release form of tacrolimus, made as extended-release capsules. It is used to prevent organ rejection after liver transplantation.
Advagraf provides once-daily dosing while maintaining effective immunosuppression. Other tacrolimus products include Prograf and Envarsus XR.
Advagraf is generally used as long-term maintenance therapy after a liver transplant. Your transplant team will monitor your blood levels, kidney function, and liver function to keep your treatment safe and effective.
WHO ADVAGRAF MAY BE SUITABLE FOR
Advagraf is prescribed to people who have received a liver transplant and need long-term prevention of organ rejection. Your healthcare provider may choose it if you prefer a once-daily tacrolimus regimen or if they want to simplify your medication schedule. It may also be used if you are switching from another tacrolimus formulation.
Because every patient's health profile is different, there is no one-size-fits-all answer. Treatment decisions are individualized and should be made by your transplant healthcare team.
PRESCRIBING OVERVIEW
Your healthcare provider may prescribe Advagraf if:
HOW ADVAGRAF CAN HELP YOUR TRANSPLANTED LIVER
After a liver transplant, your immune system can see the new liver as foreign and attack it. This is called rejection. Advagraf lowers that risk by acting on immune cells.
Advagraf blocks an enzyme in immune cells called calcineurin. This suppresses the activation of T-lymphocytes, the immune cells involved in graft rejection. The result is less immune-mediated damage to the transplanted liver.
Because Advagraf is an extended-release capsule, it maintains consistent immunosuppressive activity throughout the day. This helps preserve long-term graft function. Your transplant team checks your progress with regular tests, such as Liver Function Tests (LFTs) and blood levels of tacrolimus.
TRANSPLANT BENEFITS
After a liver transplant, your immune system can see the new liver as foreign and try to attack it. This is called rejection. Advagraf suppresses the activation of T-lymphocytes, the immune cells involved in graft rejection. By calming this response, it helps protect the transplanted liver from being attacked.
Advagraf inhibits calcineurin, an enzyme in immune cells. Blocking this enzyme reduces immune-mediated damage to the new liver. Less damage helps the organ keep working as it should.
Advagraf is an extended-release capsule, so it maintains consistent immunosuppressive activity throughout the day. The protection your new liver receives stays even rather than rising and falling. This steady effect helps keep the immune response against your graft under control day after day.
Advagraf is generally used as long-term, often lifelong, maintenance therapy after liver transplantation. Keeping the immune response under control over time helps preserve the function of your transplanted liver. Your transplant team can explain what long-term protection means for your own care.
Advagraf helps prevent rejection by calming the immune response against your transplanted liver. It should only be started and monitored under the guidance of your transplant healthcare team.
TREATMENT PROCESS
Advagraf is available as extended-release capsules. Take it exactly as prescribed, and check with your pharmacist if you have questions about your capsules.
Typical starting doses are 2-6 mg once daily. Your healthcare provider adjusts the dose regularly based on your tacrolimus blood levels, transplant status, and clinical response. Doses are often highest right after transplantation and are gradually adjusted to the lowest effective maintenance dose.
Take Advagraf once daily at the same time each morning, preferably on an empty stomach. It is an oral capsule, not an injection or infusion.
Advagraf is generally used as long-term or lifelong maintenance therapy after liver transplantation, unless your healthcare provider changes your treatment plan. Do not stop taking it without talking to your transplant team.
Store Advagraf at room temperature, away from moisture and heat.
Regular monitoring is required. It includes tacrolimus trough levels (blood levels measured before your next dose), kidney function, liver function, blood pressure, and blood glucose. Report any side effects or unusual symptoms to your transplant team.
BENEFITS AND SAFETY
Advagraf (tacrolimus) helps protect a transplanted liver by preventing rejection. Its once-daily schedule simplifies treatment and reduces the daily pill burden. Benefits vary from person to person, depending on your transplant status and how your body responds. Advagraf works best as part of a broader care plan that includes regular lab tests and transplant follow-up visits, such as Liver Function Tests (LFTs).
As with any medication, Advagraf may cause side effects. Your transplant team will monitor your blood levels, kidney function, blood pressure, and blood glucose throughout treatment and adjust your care as needed.
BENEFITS
Advagraf is taken once daily, at the same time each morning, preferably on an empty stomach. One dose a day simplifies your treatment schedule and gives you a single, predictable point in your day to take your medicine. A set routine can also make it easier to take Advagraf exactly as prescribed, without missing doses.
Once-daily dosing reduces the number of pills you take each day. This can be helpful if your healthcare provider wants to simplify your medication scheduling. Advagraf is an oral capsule, not an injection or infusion, so it fits into a daily medicine routine.
Treatment with Advagraf comes with regular checks that look at more than your medicine level. Your transplant team monitors your tacrolimus trough levels, kidney function, liver function, blood pressure, and blood glucose. These checks help them notice changes early and adjust your care. Report any side effects or unusual symptoms to your transplant team.
Your healthcare provider adjusts your dose regularly based on your tacrolimus blood levels, transplant status, and clinical response. Doses are often highest right after transplantation. They are then gradually adjusted to the lowest effective maintenance dose, so your treatment is matched to your needs.
Regular monitoring helps your transplant team catch these effects early. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support. Report any side effects or unusual symptoms to your transplant team.
SUPPORTING YOUR RESULTS
Daily habits are an important part of a comprehensive care plan alongside Advagraf. Taking your medicine consistently and keeping up with monitoring help your transplant team keep your treatment safe and effective.
These habits can support how your body responds to treatment and help protect your transplanted liver over time.
Areas that may support treatment:
Common Questions
Advagraf may be prescribed if you have received a liver transplant and need long-term prevention of organ rejection. Your healthcare provider may also consider it if you prefer a once-daily tacrolimus regimen, want a simpler medication schedule, or are moving from another tacrolimus formulation. Because every person's health profile is different, this decision is individualized. Talk with your transplant healthcare team about whether Advagraf fits your care plan and treatment goals.
Advagraf helps protect your new liver by calming the immune cells that can attack it. It blocks calcineurin, an enzyme in immune cells, which suppresses the T-lymphocyte activation involved in rejection. This reduces immune-mediated damage and helps preserve long-term graft function. Because it is an extended-release capsule, it maintains consistent protection throughout the day. Your transplant team tracks how well it is working with regular tests, so ask them how your progress is being monitored.
Take Advagraf once daily at the same time each morning, preferably on an empty stomach. It comes as extended-release capsules and should be taken exactly as prescribed, without missing doses. Your healthcare provider sets your dose and adjusts it regularly based on your tacrolimus blood levels, transplant status, and clinical response. Ask your transplant team or pharmacist about the schedule that is right for you.
Advagraf is generally used long term, often for life, as maintenance therapy after liver transplantation, unless your healthcare provider changes your treatment plan. Doses are often highest right after transplantation and are gradually adjusted to the lowest effective maintenance dose. Do not stop taking Advagraf on your own. If you have concerns about long-term use, discuss them with your transplant healthcare team.
Common side effects of Advagraf include tremor, headache, high blood pressure, elevated blood sugar, and kidney function changes. Your transplant team monitors tacrolimus trough levels, kidney function, liver function, blood pressure, and blood glucose to catch these effects early. Report any side effects or unusual symptoms to them. Avoid grapefruit and grapefruit juice, and ask your team before starting any new medication or supplement.
Yes, your healthcare provider may switch you to Advagraf if you are transitioning from another tacrolimus formulation or would benefit from a once-daily regimen. Do not change your medicine on your own. Any switch should be guided by your transplant healthcare team, who will keep monitoring your care. Ask them whether Advagraf, Prograf, or Envarsus XR best fits your needs.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
